Functional Ingredients

Azantis and Aker BioMarine on krill futures

RSS

 

Todd Norton, VP of business development at Aker BioMarine, and Mickey Schuett, then director of sales at Azantis, talk with Functional Ingredients Editor-in-Chief Todd Runestad about krill's position in the market. 

Different than omega-3s from algal sources or fish oil, krill is a phospholipid rather than a triglyceride. Emerging science suggests that the omega-3s bound to phospholipids have better bioefficiency and are utilized better by the body than those bound to triglycerides. This as well as krill's ability to deliver more DHA and EPA in a smaller capsule positions it well to compete in the crowded omega-3 space. Schuett says he believes there is room for krill as well as fish oil and algal-sourced omega-3s in the industry.

What differentiates these two krill suppliers and what opportunities do they see in the market? Watch the interview to learn more.

Please or Register to post comments.

Newhope360 newsletter: Natural Products Daily

NBJ|Engredea Monograph
The NBJ|Engredea Monograph is a series of reports filled with exclusive content on an ingredient or ingredient category, and includes market data, science, intelligence and in-depth coverage.

Available Now:

The FEAR Report
Sweeteners: 2013 Edition
Polyphenols
India
Probiotics 2013

Protein
Fibers
Exporter's Guide to the U.S. market
Ingredient Market Forecast
Omega-3s
China Edition

See upcoming topics...

 

 

Connect with Engredea